Complicaciones y mortalidad en pacientes neurocríticos / Complications and mortality in neurocritic patients

Objetivo: Relacionar las complicaciones y el riesgo de muerte en pacientes neurocríticos admitidos en la unidad de cuidados intensivos (UCI) del Hospital Universitario de Caracas durante un período de 5 meses. Métodos: investigación observacional, prospectiva, descriptiva. La muestra estuvo conformada por 65 pacientes neurocríticos, ≥ 18 años, con patologías médicas o quirúrgicas, ingresados en la UCI. El análisis estadístico incluyó la determinación de frecuencias, promedios, porcentajes y medias para descripción de variables y el T de Student. Resultados: La edad promedio fue 50,98 ± 16,66 años; la población masculinarepresentó el 50,76%. Entre las complicaciones, la mayor incidencia correspondió a las no infecciosas (70,77 %) y los trastornos ácido-básicos de tipo metabólico, la anemia y las alteraciones electrolíticas fueron las más frecuentes; el 29,23% de los pacientes presentaron complicaciones infecciosas, y la neumonía asociada a ventilación mecánica fue la más frecuente (73,91 %). La comorbilidad con mayor incidencia fue hipertensión arterial sistémica (53,84%). El 90.70% requirió ventilación mecánica y el tiempo en VM fue 4.29 ± 6.43 días. La estancia en UCI fue 5.96 ± 7.72 días. El 29,23% presentó un puntaje en la escala APACHE II entre 5-9; el SAPS II presentó mayor incidencia entre los 6-21 y 22-37 puntos con (66,70%); el SOFA al ingreso se reportó < 15 puntos en 98,46% y > 15 en 1,53%. La mortalidad del grupo fue 23,08 % (n=15). Conclusiones: Las complicaciones no infecciosas predominaron sobre las infecciosas las primeras íntimamente relacionadas con la mortalida(AU)

Objective: To relate complications and the risk of death in neurocritical patients admitted to the intensive care unit (ICU) of the University Hospital of Caracas during a period of 5 months. Methods: observational, prospective, descriptive research. The sample was made up of 65 neurocritical patients, ≥ 18 years old, with medical or surgical pathologies, admitted to the ICU.The statistical analysis included the determination of frequencies, averages, percentages and meansfor description of variables and Student's T.Results: The average age was 50.98 ± 16.66 years; the male population represented 50.76%. Among the complications, the highest incidence corresponded to non-infectious complications (70.77%) and metabolic acid-base disorders, anemia and electrolyte alterations were the most frequent; 29.23% of patients presented infectious complications, and pneumonia associated with mechanical ventilation was the most frequent (73.91%). The comorbidity with the highest incidence was systemic arterial hypertension (53.84%), 90.70% required mechanical ventilation and the time on MV was 4.29 ± 6.43 days. The ICU stay was 5.96 ± 7.72 days. 29.23% had a score on the APACHE II scale between 5-9; SAPS II presented the highest incidence between 6-21 and 22-37 points with (66.70%); The SOFA upon admission was reported to be < 15 points in 98.46% and > 15 in 1.53%. The mortality of the group was 23.08% (n=15). Conclusions: Non-infectious complications predominated over infectious complications, the former being closely related to mortalit(AU)

Hipoalbuminemia y riesgo de muerte en pacientes críticos en una unidad polivalente

Introducción: La hipoalbuminemia se puede desarrollar en las primeras horas posteriores a una enfermedad aguda y está muy relacionada con un estado inflamatorio activo, independientemente del estado nutricional del paciente. Se ha asociado con la mortalidad hospitalaria en pacientes con complicaciones postquirúrgicas, pacientes con sepsis y trauma. Objetivo: Evaluar la asociación entre los niveles de hipoalbuminemia y el riesgo de mortalidad del paciente crítico en una unidad polivalente. Métodos: Estudio observacional, descriptivo, prospectivo, de serie de casos, con 216 pacientes que ingresaron en la unidad. Se analizaron variables demográficas, clínicas, de laboratorio y se aplicó el índice pronóstico APACHE II. Se determinó la concentración de albúmina al ingreso y se clasificó la hipoalbuminemia en leve (30-35 g/L) y moderada/grave (≤ 30 g/L). Resultados: En el estudio fallecieron 28 pacientes, lo que representó un 13 % del total de pacientes ingresados. La albúmina presentó niveles bajos en 118 pacientes (54,6 %), y de estos, 66 (56 %) presentaron cifras inferiores a los 30 g/L; o sea, una hipoalbuminemia moderada o grave. Los pacientes con hipoalbuminemia moderada-grave tuvieron un riesgo de muerte superior (23,5 %) a aquellos con niveles clasificados como leve (15,3 %), diferencia estadísticamente significativa (p= 0,034); y en el grupo de pacientes con hipoalbuminemia moderada- grave falleció el 67 %, en relación con el 33 % de los pacientes con niveles clasificados como leve. Conclusiones: La hipoalbuminemia moderada-grave se asocia con el riesgo de mortalidad, independientemente del diagnóstico al ingreso.

Introduction: Hypoalbuminemia can develop in the first hours after an acute illness, and is closely related to an active inflammatory state, regardless of the patient's nutritional status. It has been associated with hospital mortality in patients with post-surgical complications, patients with sepsis and trauma. Objective: To evaluate the association between hypoalbuminemia level and the risk of mortality in critically ill patients in a polyvalent unit. Methods: Observational, descriptive, prospective, case series study, with 216 patients admitted to the unit. Demographic, clinical, and laboratory variables were analyzed and the APACHE II prognostic score was applied. Albumin concentration is calculated on admission and hypoalbuminemia is classified as mild (30-35 g/L) and moderate/severe (≤ 30 g/L). Results: In the study, 28 patients died, which represented 13% of the total number of patients admitted. Albumin levels were low in 118 patients (54.6%), and of these 66 patients (56%) were classified as hypoalbuminemia moderate/severe, with albumin values below 30 g/L. Patients with moderate-severe hypoalbuminemia had a higher risk of death (23.5%) than those patients with levels classified as mild (15.3%), a statistically significant difference (p= 0.034); and in the group of patients with moderate-severe hypoalbuminemia, 67% died, in relation to 33% of patients with levels classified as mild. Conclusions: Moderate-severe hypoalbuminemia is associated with mortality risk, regardless of admission diagnosis.

Comparing the Prognosticative Value of APACHE II and mSOFA Scores in Critically Ill Patients: A Prospective Study

Objective: Several predictive scoring systems measuring disease severity are used to predict outcomes, typically mortality, of critically ill patients in the intensive care unit (ICU). Two common validated predictive scoring systems include acute physiology and chronic health evaluation II (APACHE II) and modified sequential organ failure assessment score (mSOFA). To compare performance of APACHE II and mSOFA score in critically ill patients regarding the outcomes in the form of morbidity and mortality in ICU. Methods: This prospective observational clinical study was conducted on 100 patients over 6 months. For each patient, APACHE II score on day of admission and serial mSOFA scores on day 0, 3, 7 and 10 were calculated and compared. Results: The age of the non-survivors was significantly older than survivors was (57.1±11.76 and 54.28±15.16). [In our study we found that the mean length of ICU stay of non-survivors was (5.41±4.81) & survivors(8.63± 4.81) days.] In our study mortality rate was 40%.The APACHE II score with cut-off point of 23 demonstrated a sensitivity rate of 98.33% & specificity rate of 17.5%, accuracy of 66.00%. Serial mSOFA scores with cut-off of 11 on day0, day3, day7 better differentiated survivors from non-survivors with 98.3% sensitivity, 27.5% specificity and 70% accuracy. Conclusion: Both APACHE II and mSOFA scores can help ICU physicians as a significant predictive marker for mortality in critically ill patients. The serial measurement of mSOFA score in the first week is a better mortality predictor tool than APACHE II score in critically ill patients.

Mortality of Elderly Patients Supported by Mechanical Ventilation at a General Critical Care Unit in a Tertiary Care Centre

Background : There has been a steady rise in the geriatric population in India and increasing number of elderly patients are being admitted in Critical Care Unit (CCU). They need mechanical ventilation during their hospital stay. Hence, there is continued need for evaluation and research to develop a validating scoring systems used to predict the outcome of CCU patients supported by mechanical ventilation. Objective : Analysis to predict the outcome (survival or mortality) of mechanically ventilated elderly patients in different age groups at the CCU. Material and Method : A Prospective observational study was done in CCU for a period of one year. A group of 40 elderly ventilated patients greater than 60 years of age (Group 1-elderly case group) and another group of 40 ventilated patients less than 60 years of age (Group-2- control group) were included in the study. A clinical database was collected which included age, sex, Acute Physiology and Chronic health Evaluation II (APACHE II) score and an Sequential Organ Failure Assessment (SOFA) scores were calculated in the first 24 hours of ventilation,indication of mechanical ventilation, co-morbidity, according to the Charlson Comorbidity Index (CCI), functional capacity according to the Barthel Index (BI). Patients outcome (survival or mortality) were analyzed. All the patients in two groups were on ventilation support. Result : In case group (n=40), mortality was 55%. In control group (n=40), mortality was 52.5%. On comparison of outcome between two groups (case with control group) the difference was not statistically significant (p= 0.8225). In case group, association of outcome to different age groups (60-65 years, 66-75years, more than75years) (p=0.3357) andto gender (p=0.3854) was not statistically significant. Multivariate logistic regression analysis of the study variables showed APACHE II score to be statistically significant for outcome (p=0.0229). Conclusion : Mortality of elderly patients supported by mechanical ventilation at CCU were slightly higher(55%) than in mechanically ventilated younger populations (52.5%) though the difference was not statistically significant between two groups (p=0.82). APACHE II, score measured within 24 hours of ventilation was a significant predictor of mortality in the patients on mechanical ventilation.

Role of Procalcitonin Levels in Patients with Sepsis in Medical Intensive Care Unit

Introduction: Sepsis has a death rate of ?25% globally and its clinical treatment presents an important clinical challenge. The Acute Physiology and Chronic Health Evaluation II (APACHE II) is the standard method for assessing sepsis. Serum PCT level can be increase in case of sepsis. With this background, the present research is aimed to study the survival among the sepsis cases and correlate them with serum procalcitonin levels, APACHE II Score and other risk factors. Methodology: The study was conducted among 75 cases diagnosed having sepsis admitted in medical ICU. APACHE II score, serum procalcitonin (PCT) and other investigation were carried out along with clinical history and examination. Data were analysed using epi-info software. Results: The cases fatality rate of sepsis cases in medical intensive care unit in our hospital was 37.3%. The mortality rate was significantly higher patients with comorbidities, especially cases with respiratory or CNS involvement. The serum PCT levels were significantly higher in the group of non survivors as compared to group of survivors. Higher APACHE II score associated with higher mortality. Serum PCT levels go on increasing along the spectrum of sepsis. A PCT level was significantly hire in culture positive cases compare to sterile cases. Conclusion: From this study we conclude that serum PCT level is useful investigation in sepsis cases to predict mortality

Delta de ácido úrico como predictor de severidad en pacientes con SARS-CoV-2 / Delta uric acid as a predicator of severity in patients with SARS-CoV-2 / Delta do ácido úrico como preditor de gravidade em pacientes com SARS-CoV-2

Resumen Introducción: El SARS-CoV-2 representa la primera causa de mortalidad actual en la población mexicana, a nivel global se han acumulado 1'919,126 defunciones. Las regiones con más muertes son América (47%) y Europa (33%). Hasta la semana 2 del año 2021 en México se estimaban 1'541,633 casos, siendo la Ciudad de México la entidad más afectada; hasta ese momento se habían registrado 18,443 fallecimientos, con una necesidad hospitalaria de 80% y con alta demanda de hospitalización en el servicio de Unidad de Cuidados Intensivos (UCI). Por esta razón, surge la necesidad de nuevos marcadores tempranos de severidad y pronóstico. Objetivo: Correlacionar el delta de ácido úrico (DAU) con la mortalidad en pacientes con SARS-CoV-2 tratados en la UCI, así como su relación con otras variables de severidad. Material y métodos: Se realizó un estudio longitudinal en una UCI con 71 pacientes; las variables de estudio fueron: demográficas, comorbilidades, días de estancia en la UCI, días de ventilación mecánica (VM), escala predictora de mortalidad, ácido úrico inicial y ácido úrico final, DAU; desenlace: mortalidad. Resultados: De los participantes, 69% fueron varones, 31% mujeres, edad promedio de 54.35 años (± 10.28), ácido úrico al ingreso de 3.9 mg/dL (± 1.74), ácido úrico al egreso de 2.89 mg/dL (± 1.70), delta de ácido úrico promedio de 1.077 mg/dL (± 1.59), APACHE II al ingreso de 18.35 puntos (± 9.04) y al egreso de 22.95 puntos (± 19.68), mortalidad global de 50.7%, de los cuales 78.67% requirió ventilación mecánica y 21.12% no la requirió. La correlación de Spearman para DAU y mortalidad fue r = -0.34, el índice de determinación r2 = 0.13, con significancia p = 0.004, (IC) 95%. Conclusiones: Se demostró la correlación entre el DAU con la mortalidad de los pacientes con SARS-CoV-2 con adecuada significancia estadística a un intervalo de corte de 1-1.5 mg/dL y una mortalidad de 50.7%. Adicionalmente, se demostró que dicho intervalo tuvo correlación con el inicio de la ventilación mecánica. Se identificó que sí existe relación entre la puntuación de APACHE II y la mortalidad por SARS-CoV-2; para este estudio un puntaje mayor a 18 demostró la mejor significancia estadística.

Abstract Introduction: SARS-CoV-2 represents the first cause of current mortality in the Mexican population, globally it has accumulated 1'919,126 deaths. The regions with the most deaths are America (47%), Europe (33%). Until week two of 2021 in Mexico, 1'541,633 cases were estimated, with Mexico City being the most affected entity, until that moment 18,443 deaths had been registered, with a hospital need of 80%, and with a high demand for hospitalization in the service of Intensive Care Unit (ICU). For this reason, the need arises for new early markers of severity and prognosis. Objective: To correlate the uric acid delta (DAU) with mortality in patients with SARS-CoV-2 treated in the ICU, as well as its relationship with other variables of severity. Material and methods: A longitudinal study was carried out in the ICU with 71 patients and study variables: demographic, comorbidities, days of ICU stay, days of mechanical ventilation (MV), predictive mortality scale, initial uric acid and final uric acid, DAU; outcome: mortality. Results: Of the participants, 69% were men, 31% women, mean age of 54.35 years (± 10.28), uric acid at admission of 3.9 mg/dL (± 1.74), uric acid at discharge of 2.89 mg/dL (± 1.70), mean uric acid delta of 1.077 mg/dL (± 1.59 mg/dL), APACHE II at entry of 18.35 points (± 9.04) at discharge of 22.95 points (± 19.68), global mortality of 50.7%, of which 78.67% required mechanical ventilation (MV) and 21.12% did not require. The Spearman correlation for DAU and mortality was r = -0.34, the determination index r2 = 0.13, with significance p = 0.004, (CI) 95%. Conclusions: The correlation between the DAU with the mortality of the patients with SARS-CoV-2 was demonstrated with adequate statistical significance at a cut-off interval of 1-1.5 mg/dL, and a mortality of 50.7%. Additionally, it was shown that said interval had a correlation with the start of mechanical ventilation. It was identified that if there is a relationship between the APACHE II score and SARS-CoV-2 mortality, for this study a score greater than 18 demonstrated the best statistical significance.

Resumo Introdução: O SARS-CoV-2 representa a primeira causa de mortalidade atual na população mexicana, globalmente acumulou 1.919.126 mortes. As regiões com mais mortes são América (47%), Europa (33%). Até a semana 2 de 2021 no México, foram estimados 1.541.633 casos, sendo a Cidade do México a entidade mais afetada, até então foram registrados 18.443 óbitos, com necessidade hospitalar de 80% e com alta demanda de internação no serviço de emergência Unidade de Terapia Intensiva (UTI). Por esta razão, há necessidade de novos marcadores precoces de gravidade e prognóstico. Objetivo: Correlacionar o delta do ácido úrico (DAC) com a mortalidade em pacientes com SARS-CoV-2 atendidos na UTI, bem como sua relação com outras variáveis de gravidade. Material e métodos: Realizou-se um estudo longitudinal na UTI com 71 pacientes e variáveis de estudo: demografia, comorbidades, dias de internação na UTI, dias de ventilação mecânica (VM), escala preditiva de mortalidade, ácido úrico inicial e ácido úrico final, DAC; resultado: mortalidade. Resultados: Dos participantes, 69% eram homens, 31% mulheres, idade média 54.35 anos (± 10.28), ácido úrico na admissão 3.9 mg/dL (± 1.74), ácido úrico na alta 2.89 mg/dL (± 1.70), delta de ácido úrico médio de 1.077 mg/dL (± 1.59 mg/dL), APACHE II na admissão de 18.35 pontos (± 9.04) na alta de 22.95 pontos (± 19.68), mortalidade geral de 50.7%, dos quais 78.67% necessitaram de ventilação mecânica (VM) e 21.12% não necessitaram. A correlação de Spearman para DAU e mortalidade foi r = -0.34, o índice de determinação r2 = 0.13, com significância p = 0.004, (IC) 95%. Conclusões: Demonstrou-se a correlação entre o DAU com a mortalidade de pacientes com SARS-CoV-2 com adequada significância estatística no intervalo de corte de 1-1.5 mg/dL e mortalidade de 50.7%. Além disso, foi demonstrado que esse intervalo se correlacionou com o início da ventilação mecânica. Identificou-se que existe relação entre o escore APACHE II e a mortalidade por SARS-CoV-2, para este estudo um escore maior que 18 apresentou a melhor significância estatística.

Caracterización de pacientes con pancreatitis aguda en una unidad de cuidados intensivos polivalente / Characterization of patients with Acute Pancreatitis in the multipurpose intensive care unit

RESUMEN Introducción: La pancreatitis es la inflamación del páncreas exocrino, resultado del daño a las células acinares. Sus características clínicas principales son el dolor abdominal y la elevación de los niveles séricos de amilasa y lipasa. La evolución es muy variable, desde una recuperación completa de un primer episodio, hasta una enfermedad crónica debilitante, o la muerte. Objetivos: Caracterizar a los pacientes ingresados en la unidad de cuidados intensivos, con el diagnóstico de pancreatitis aguda y evaluarlos según los criterios de gravedad. Métodos: Se realizó un estudio descriptivo en el que se revisaron 46 historias clínicas de pacientes ingresados con diagnóstico de pancreatitis aguda en la unidad de terapia intensiva polivalente, desde enero del 2014 a diciembre del 2019. Se confeccionó una base de datos con las variables edad, etiología, complicaciones, letalidad y la aplicación de escalas de Ranson, APACHE II y Balthazar-Hill, para evaluar evolutivamente la gravedad y pronóstico. Se hizo un análisis de frecuencias de dichas variables. Resultados: La edad de mayor incidencia correspondió a los grupos menores de 61 años, con predominio del sexo masculino. La causa más frecuente fue la litiasis vesicular y el alcoholismo, para un 43,4 % y 34,7 % respectivamente. El 47,8 % presentó la forma leve de la enfermedad. La letalidad fue del 21,7 %. Conclusiones: Son más frecuentes las formas graves de la enfermedad; la insuficiencia renal aguda y la insuficiencia respiratoria aguda son las complicaciones más representativas.

ABSTRACT Introduction: Pancreatitis is the inflammation of the exocrine pancreas, as a result of damage to the acinar cells. Its main clinical features are abdominal pain and elevated serum levels of amylase and lipase. The evolution is very variable, from a complete recovery from a first episode, to a debilitating chronic disease, or death. Objectives: To characterize patients admitted to the intensive care unit with a diagnosis of acute pancreatitis and to evaluate them according to severity criteria. Methods: A descriptive study was carried out in which 46 medical records of patients admitted with a diagnosis of acute pancreatitis in the multipurpose intensive care unit were reviewed, from January 2014 to December 2019. A database was created with the variables age, etiology, complications, lethality and the application of the Ranson, APACHE II and Balthazar-Hill scales, to evaluate severity and prognosis. An analysis of the frequencies of these variables was carried out. Results: The age with the highest incidence corresponded to groups under 61 years of age, with a predominance of males. The most frequent cause was gallstones and alcoholism, for 43.4 % and 34.7 % respectively. 47.8 % presented the mild form of the disease. The lethality was 21.7 %. Conclusions: Severe forms of the disease are more frequent; acute renal failure and acute respiratory failure are the most representative complications.

Outcome of Patients with Sepsis Admitted in Intensive Care Unit of a Tertiary Care Hospital in India

Introduction: Sepsis has a death rate of ?25% globally and its clinical treatment presents an important clinical challenge. The rapid progression of sepsis requires correspondingly swift adjustments in therapy, and accurate identification of disease severity is therefore vitally important for predicting prognosis, treatment, preventing complications, reducing complication and mortality. With this background, the present research is aimed to study the relation of serum procalcitonin levels in cases with sepsis, to calculate APACHE II scores and to correlate the levels of serum PCT levels with APACHE II Score with the outcome. Methodology: This was a prospective observational non interventional cohort study was conducted in the Clinic of Intensive Care unit of a tertiary care hospital and medical college in western India from May 2020 to December 2020. Results: A total of 75 patients, admitted to the ICU with the diagnosis of sepsis, were included in this prospective observational study. Of them 47 (62.7%) were males and highest cases were aged between 60 to 69 years. Of the total 75 patients, 47 (62.7%) patients were survivors. Age, gender and involvement of system were not associated with mortality while lower APACHE II score and presence of co-morbidities were significantly associated with mortality. Conclusion: From this study we conclude that the lower APCHE II score and presence of co-morbidity significantly increases the mortality in ICU patients admitted with sepsis

Obesidad como factor pronóstico en el paciente crítico / Obesity as a prognostic factor in the critical ill patients / Obesidade como fator prognóstico no paciente crítico

Resumen: Introducción: La obesidad es una enfermedad con impacto negativo en la sobrevida; se hace referencia al término «paradoja de la obesidad¼ utilizado como un efecto protector en la mortalidad. Objetivo: Determinar si la obesidad es un factor de protección en el paciente crítico. Material y métodos: Se realizó un estudio de cohorte. Se obtuvo información de expedientes de Unidad de Cuidados Intensivos (UCI) del Hospital Regional Monterrey del Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado (ISSSTE) Monterrey durante 2018. Se hizo análisis bivariado para asociación χ2 y U de Mann-Whitney para correlación fórmula de Pearson y análisis de supervivencia con curva de Kaplan-Meier. Resultados: Se analizaron 151 expedientes de pacientes, 73 obesos y 78 no obesos, se observó que la obesidad es un factor protector para mortalidad (p = 0.044, OR 0.431 (IC 0.187-0.992). El IMC no se correlaciona con el Acute physiology and chronic health evaluation (APACHE) II (p = 0.066); sin embargo, con un impacto en la curva de supervivencia (p = 0.42). Conclusiones: Se detecta la obesidad como factor protector; sin embargo, su asociación con enfermedades crónicas degenerativas, estancia prolongada en UCI y sus complicaciones no dejan de tener impacto negativo en la supervivencia fuera de la unidad.

Abstract: Introduction: Obesity is a disease with a negative impact on survival; the prognosis of these patients is has controversial results. The term «obesity paradox¼ refers as a protective effect on mortality. Objective: To determine whether obesity is a protective factor in the critically ill patient. Material y methods: A cohort study was conducted. Data was obtained from ICU records of the ISSSTE Monterrey Regional Hospital during 2018, bivariate analysis was performed for χ2 and Mann Whitney's U association, for Pearson's formula correlation and survival analysis with Kaplan-Meier curve. Results: 151 records of 73 obese and 78 non-obese patients were analyzed, it was observed that obesity is a protective factor for mortality (p = 0.044, OR 0.431(IC 0.187-0.992), BMI does not correlate with APACHE II (p = 0.066), however, an impact on the survival curve was observed (p = 0.42). Conclusions: According to the results obtained, it matches with the term «obesity paradox¼, however, its association with chronic degenerative diseases, prolonged stay in the ICU and its complications do not cease to have a negative impact on survival outside the unit.

Resumo: Introdução: A obesidade é uma doença com impacto negativo na sobrevida; O termo «paradoxo da obesidade¼ refere-se a um efeito protetor sobre a mortalidade. Objetivo: Determinar se a obesidade é um fator protetor em pacientes críticos. Material e métodos: Foi realizado um estudo de coorte. As informações foram obtidas dos registros da UTI do ISSSTE Monterrey Regional Hospital durante o ano de 2018, foi realizada análise bivariada para associação χ2 eU Mann-Whitney, para correlação da fórmula de Pearson e análise de sobrevida com curva de Kaplan-Meier. Resultados: Foram analisados 151 prontuários de 73 pacientes obesos e 78 não obesos, observou-se que a obesidade é fator protetor para mortalidade (p = 0.044, OR 0.431(IC 0.187-0.992), IMC não se correlaciona com APACHE II (p = 0.066), porém, com impacto na curva de sobrevida (p = 0.42). Conclusões: A obesidade é encontrada como fator de proteção, porém, sua associação com doenças crônico-degenerativas, permanência prolongada na UTI e suas complicações não deixam de ter impacto negativo na sobrevida fora da unidade.

A Study of Hypomagnesemia in Patients Admitted in Medical ICU and Its Correlation with Final Outcome

Introduction: Magnesium is the second most common intracellular cation found in the body that is required as cofactor in numerous enzymatic reactions, smooth functioning of cardiac and neurological systems. Magnesium deficiency is often overlooked in critically ill patients and is linked with risk of electrolyte imbalance, difficulty weaning off ventilator, sudden cardiac deaths and poorer outcome. Objective- To assess prevalence of magnesium deficiency in critically ill patients admitted to Medical ICU and its association with requirement & duration of mechanical ventilation, ICU stay, APACHE-II & mortality. Methods- Prospective descriptive study was conducted on 69 critically ill patients admitted in medical ICU. After taking informed consent serum magnesium level of patients were collected and entered in spreadsheet and final analysis was done with help of Open EPI and SPSS software. Results-It was concluded that patients having hypomagnesemia were at increased risk of electrolyte abnormalities, longer ventilatory support, longer hospital and ultimately poorer outcome stay as compared to patients with normal magnesium levels. Conclusion- Magnesium remains an important but often side-lined cation in critically ill patients. However, Hypomagnesemia is a repeated finding seen in critically ill patients and is significantly associated with a higher mortality rate and frequent need for mechanical ventilation.

Decaf Score in Predicting Prognosis of Acute Exacerbation of Copd in Patient Required Hospital and ICU Admission

@#Introduction: Exacerbation refers to deterioration of patient’s respiratory indications and requires a robust scoring tool for subjects suffering from Chronic Obstructive Pulmonary Disease (COPD) undergoing acute exacerbation. The Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation (DECAF) score can be utilized bedside and predicts in-hospital mortality using indices. The study aimed at assessing the prognostic standards (of duration of ICU stay, hospital stay and mortality) and the sensitivity and specificity of acute exacerbation of COPD patients based on DECAF score. Methods: This prospective study was carried out in a tertiary hospital with 84 patients between October 2016 to September 2018. On admission, DECAF score of all patients with acute exacerbation of COPD was noted and admitted to ICU. The mean duration of stay in ICU and hospital were compared. Various components of APACHE II, BAP 65, CURB 65 were also noted on admission. Results: Mean age of population was 68.29±11.80 with male predominance (68%). The study observed mortality in 6% of patients with mean ICU stay of 3.65±2.21 days and mean hospital stay of 6.45±3.28 days. For a score of 5 and 6 mean DECAF score could not be calculated as the mortality rate was 100%. ROC of DECAF score was 0.81 which was more than APACHE II (0.72) and BAP 65 (0.69) (p-value 0.07 and 0.056 suggested significance). Conclusion: The DECAF Score has been observed to be a stronger predictor for hospital mortality. Higher the DECAF score, higher is the in-hospital death rate. The DECAF score also helps in forecasting the duration of ICU stay and hospital stay.

Poisoning Severity Score And Its Correlation With APACHE II And Glasgow Coma Scale In Predicting Outcome In Patients Presented With Poisoning In Emergency Department

Background:Standardized scales for scoring severity of poisoning is need of time in Emergency department(ED)to identify high risk patients for intensive monitoring and treatment before disposal and for compatibility of data. So in this study we try to evaluate utility of Glasgow coma scale (GCS), poisoning severity score (PSS) and Acute physiology and chronic health evaluation II (APACHE II) in estimating clinical severity and prognosis of poisoning patients.Material and methods: A Retrospective observational study was conducted between1stJune 2019 to 28thFebruary 2021 in the Emergency Department of tertiary care teaching hospital, Ahmedabad, India. Data was collected from computerized hospital information system and analysed in CDC software Epi Info (version 7.3.2.1).Results:Out of total 50 patients during study,majority of patients were in age group of 21-30 year (yr)with Male: Female ratio of 1:1. Out of 50 cases, 44 consumed chemical substances, 3 had corrosive and 3 had medication consumption with organophosphates (OP) being most common compound. Mean PSS in expired was significantly high in comparisonof survivors (p value= 0.0118). Present study found significant association between PSS within first 24 hours and GCS of patients pre sented with poisoning with p value 0.0117 (GCS on admission) and 0.0002 (GCS at 24 hr). A statistically significant correlation was found between PSS and APACHE II, with a p value= 0.0242 and also between GCS and APACHE II with a p value= 0.0018 (CI=95%).Conclusion:Both PSS and GCSare effective in predicting Severity and outcome of patients presented with poisoning in ED.GCSis more useful as it is easy to use, does not require any laboratory investigations and less time consuming.

Experiencia en el cuadro clínico, diagnóstico y tratamiento de COVID-19 / Experience in the clinical picture, diagnosis and treatment of COVID-19 / Experiência no quadro clínico, diagnóstico e tratamento da COVID-19

Resumen: Introducción: La infección por SARS-CoV-2 en Wuhan, China, ocasionó una pandemia de tal magnitud que ha provocado la muerte por neumonía a causa de enfermedad infecciosa por coronavirus 19 (COVID-19) de millones de personas. Nos dimos a la tarea de recolectar todas las características de los pacientes que estuvieron hospitalizados por esta enfermedad en nuestra UCI adultos. Material y métodos: Se realizó un estudio de tipo analítico, descriptivo, observacional y retrospectivo en pacientes con diagnóstico de COVID-19 ingresados en la Unidad de Cuidados Intensivos (UCI) del Hospital Ángeles Clínica Londres en la Ciudad de México, evaluados en el periodo del 23 de marzo de 2020 al 10 de mayo de 2020. Se revisaron los expedientes y se tomaron los datos de los mismos, se describieron variables de tipo demográfico, factores de riesgo, signos y síntomas, tratamiento médico y atención respiratoria. Se revisaron escalas de mortalidad SAPS III, APACHE II, SOFA y CALL-score. Se formaron dos grupos con y sin mortalidad realizándose análisis bivariado y multivariado de las variables significativas. El análisis estadístico se efectuó con el programa SPSS 25. Resultados: En el periodo considerado, 25 expedientes cumplieron con los criterios de inclusión, de ellos la demografía y factores de riesgo, 18 (72%) correspondieron a hombres y siete (38%) a mujeres con una mortalidad de 10 (40%). Los factores de riesgo más frecuentes fueron diabetes mellitus (DM) en siete (38%) pacientes, hipertensión arterial (HAS) en seis (24%), obesidad en cuatro (16%), enfermedad pulmonar obstructiva crónica (EPOC) en uno (4%), tabaquismo en 11 (44%) y alcoholismo en siete (28%). Se encontraron diferencias estadísticamente significativas en los grupos sin mortalidad y con mortalidad, 15 y 10 pacientes, respectivamente, observando las siguientes significancias: glucosa 105 mg/dL (percentil [PE 88]) versus 171 mg/dL (PE 125) p = 0.012, urea 33 mg/dL (PE 22) versus 95 mg/dL (PE 57) p = 0.03, BUN 15.3 mg/dL (PE 11) versus 44.2 mg/dL (PE 26.28) p = 0.04, TGO 32 U/L (PE 24.4) versus 58 U/L (PE 43.8) p = 0.010, DHL 239 U/L (PE 198) 454 U/L (PE 260) p = 0.003, triglicéridos 148 mg/dL (PE 120) versus 187.5 mg/dL (PE 165) p = 0.002, CPK 70 U/L (PE 35) versus 81 U/L (PE 78.25) p = 0.003, ferritina 446 mg/L (PE 238) versus 1,030 mg/L (PE 665) p = 0.007. Se realizó un análisis bivariado con regresión logística binaria, con la variable mortalidad dicotómica, no resultando significativa con esta prueba. Conclusiones: Se entiende que ninguna variable es predominantemente importante para explicar la mortalidad y que se recurre a muchos factores que se conjugan para explicar este desenlace, uno de éstos es la severidad misma del problema respiratorio en que se encuentre el paciente.

Abstract: Introduction: The SARS-CoV-2 infection in Wuhan, China caused a pandemic of such magnitude that it has caused the death of millions of people from pneumonia due to infectious disease caused by coronavirus 19 (COVID-19). We took on the task of collecting all the characteristics of the patients who were hospitalized for this disease in our Adult Intensive Care Unit. Material and methods: An analytical, descriptive, observational and retrospective study was carried out in patients with a diagnosis of COVID-19 admitted to the Intensive Care Unit (ICU) of the Hospital Ángeles Clínica Londres in Mexico City, evaluated in the period of March 23 from 2020 to May 10, 2020. The files were reviewed and the data taken from them, demographic variables, risk factors, signs and symptoms, medical treatment and respiratory care were described. SAPS III, APACHE II, SOFA and CALL-score mortality scales were reviewed. Two groups were formed with and without mortality, performing bivariate and multivariate analyzes of the significant variables. Statistical analysis was performed with the SPSS 25 program. Results: In the period considered, 25 files met the inclusion criteria for them: demographics and risk factors were 18 (72%) corresponding to men and seven (38%) to women. With a mortality of 10 (40%). The most frequent risk factors are diabetes mellitus (DM) in seven (38%), arterial hypertension (SAH) six (24%), obesity four (16%), chronic obstructive pulmonary disease (COPD) one (4%), smoking 11 (44%) and alcoholism seven (28%). Statistically significant differences were found in the groups without mortality and with mortality 15 and 10 patients respectively, observing the following significance: glucose 105 mg/dL (percentil [PE] 88) versus 171 mg/dL (PE 125) p = 0.012, urea 33 mg/dL (PE 22) versus 95 mg/dL (PE 57) p = 0.03, BUN 15.3 mg/dL (PE 11) versus 44.2 mg/dL (PE 26.28) p = 0.04, TGO 32 U/L (PE 24.4) versus 58 U/L (PE 43.8) p = 0.010, DHL 239 U/L (PE 198) 454 U/L (PE 260) p = 0.003, triglycerides 148 mg/dL (PE 120) versus 187.5 mg/dL (PE 165) p = 0.002, CPK 70 U/L (PE 35) versus 81 U/L (PE 78.25) p = 0.003, ferritin 446 mg/L (PE 238) versus 1,030 mg/L (PE 665) p = 0.007. A bivariate analysis with binary logistic regression was performed, with the dichotomous mortality variable, not resulting in this significant test. Conclusions: It is understood that no variable is predominantly important to explain mortality and that many factors are involved that are combined to explain this outcome, one of these being the same severity of the respiratory problem in which the patient is.

Resumo: Introdução: A infecção por SARS-CoV-2 em Wuhan China causou uma pandemia de tal magnitude que causou a morte de milhões de pessoas por pneumonia devido a doença infecciosa causada pelo coronavírus 19 (COVID-19). Assumimos a tarefa de coletar todas as características dos pacientes internados por essa doença em nossa unidade de terapia intensiva adulto. Material e métodos: Realizou-se um estudo analítico, descritivo, observacional e retrospectivo em pacientes com diagnóstico de COVID-19 internados na Unidade de Terapia Intensiva (UTI) do Hospital Ángeles Clínica Londres na Cidade do México, validado para o período de 23 de março de 2020 a 10 de maio de 2020. Os prontuários médicos foram revisados e seus dados coletados, as variáveis do tipo demográficas foram descritas, fatores de risco, sinais e sintomas, tratamento médico e cuidados respiratórios. Foram revisadas as escalas de mortalidade SAPS III, APACHE II, SOFA e CALL-score. Dois grupos foram formados com e sem mortalidade, realizando análises bivariadas e multivariadas das variáveis significativas. A análise estatística foi realizada com o programa SPSS 25. Resultados: No período considerado, 25 prontuários atenderam aos critérios de inclusão para os mesmos: dados demográficos e fatores de risco foram 18 (72%) correspondentes a homens e 7 (38%) a mulheres. Com mortalidade de 10 (40%). Os fatores de risco mais frequentes são diabetes mellitus (DM) em 7 (38%), hipertensão arterial (HAS) 6 (24%), obesidade 4 (16%), doença pulmonar obstrutiva crônica (DPOC) 1 (4%), tabagismo 11 (44%) e alcoolismo 7 (28%). Encontrou-se diferenças estatisticamente significativas nos grupos sem mortalidade e com mortalidade de 15 e 10 pacientes respectivamente, observando a seguinte significância: glicose 105 mg/dL (percentil [PE] 88) versus 171 mg/dL (PE 125) p = 0.012, uréia 33 mg/L (PE 22) versus 95 mg/L (PE 57) p = 0.03, BUN 15.3 mg/L (PE 11) versus 44.2 mg/L (PE 26.28) p = 0.04, TGO 32 U/L (PE 24.4) versus 58 U/L (PE 43.8) p = 0.010, DHL 239 U/L (PE 198) 454 (PE 260) p = 0.003, triglicerídeos 148 mg/dL (PE 120) versus 187.5 mg/dL (PE 165) p = 0.002, CPK 70 U/L (PE 35) versus 81 U/L (PE 78.25) p = 0.003, ferritina 446 mg/L (PE 238) versus 1030 mg/L (PE 665) p = 0.007. Realizou-se análise bivariada com regressão logística binária, com a variável mortalidade dicotômica, não resultando em teste significativo. Conclusões: Entende-se que nenhuma variável é predominantemente importante para explicar a mortalidade e que usamos muitos fatores que se conjugam para explicar esse desfecho, sendo um deles a mesma gravidade do problema respiratório em que o paciente se encontra.

Valor pronóstico del sistema de calificación APACHE II en el postoperatorio de cirugía cardíaca / Prognostic value of APACHE II score in postoperative of cardiac surgery

Resumen Antecedentes y objetivos: El sistema de calificación APACHE II permite predecir la mortalidad intrahospitalaria en terapia intensiva. Sin embargo, no está validado para cirugía cardíaca, ya que no posee buena capacidad diferenciadora. El objetivo es determinar el valor pronóstico de APACHE II en el postoperatorio de procedimientos cardíacos. Materiales y métodos: Se analizó en forma retrospectiva la base de cirugía cardíaca. Se incluyó a pacientes intervenidos entre 2017 y 2018, de los cuales se calculó la puntuación APACHE II. Se utilizó curva ROC para determinar el mejor valor de corte. El punto final primario fue mortalidad intrahospitalaria. Como puntos finales secundarios se evaluó la incidencia de bajo gasto cardíaco (BGC), accidente cerebrovascular (ACV), sangrado quirúrgico y necesidad de diálisis. Se realizó un modelo de regresión logístico multivariado para ajustar a las variables de interés. Resultados: Se analizó a 559 pacientes. La media del sistema de calificación APACHE II fue de 9.9 (DE 4). La prevalencia de mortalidad intrahospitalaria global fue de 6.1%. El mejor valor de corte de la calificación para predecir mortalidad fue de 12, con un área bajo la curva ROC de 0.92. Los pacientes con APACHE II ≥ 12 tuvieron significativamente mayor mortalidad, incidencia de BGC, ACV, sangrado quirúrgico y necesidad de diálisis. En un modelo multivariado, el sistema APACHE II se relacionó de modo independiente con mayor tasa de mortalidad intrahospitalaria (OR, 1.14; IC95%, 1.08-1.21; p < 0.0001). Conclusiones: El sistema de clasificación APACHE II demostró ser un predictor independiente de mortalidad intrahospitalaria en pacientes que cursan el postoperatorio de cirugía cardíaca.

Abstract Background and objectives: The APACHE II score allows predicting in-hospital mortality in patients admitted to intensive care units. However, it is not validated for patients undergoing cardiac surgery, since it does not have a good discriminatory capacity in this clinical scenario. The aim of this study is to determine prognostic value of APACHE II score in postoperative of cardiac surgery. Materials and methods: The study was performed using the cardiac surgery database. Patients undergoing surgery between 2017 and 2018, with APACHE II score calculated at the admission, were included. The ROC curve was used to determine a cut-off value The primary endpoint was in-hospital death. Secondary endpoints included low cardiac output (LCO), stroke, surgical bleeding, and dialysis requirement. A multivariable logistic regression model was developed to adjust to various variables of interest. Results: The study evaluated 559 patients undergoing cardiac surgery. The mean of APACHE II Score was 9.9 (SD 4). The prevalence of in-hospital death was 6.1%. The best prognostic cut-off value for the primary endpoint was 12, with a ROC curve of 0.92. Patients with an APACHE II score greater than or equal to 12 had significantly higher mortality, higher incidence of LCO, stroke, surgical bleeding and dialysis requirement. In a multivariate logistic regression model, the APACHE II score was independently associated with higher in-hospital death (OR, 1.14; 95CI%, 1.08-1.21; p < 0.0001). Conclusions: The APACHE II Score proved to be an independent predictor of in-hospital death in patients undergoing postoperative cardiac surgery, with a high capacity for discrimination.

Mannheim’s peritonitis index a more simpler prognostic index than APACHE II score

Background: The study was done with the aim to determine the clinical profile of patients with hollow viscous perforation and to compare MPI and APACHE II scoreMethods: This study was a prospective and retrospective observational study conducted in the department of General Surgery, Gandhi Medical College and associated Hamidia Hospital from the June 2017 to August 2019The possible score ranges from 0-47. All necessary preoperative data was recorded. Blood sample was taken and relevant blood investigations were done. Patients were resuscitated with iv fluids. Nasogastric tube and urinary cather insertion were done. The parameters of modified APACHE II score and Manheim’s peritonitis index were recorded at the time of admission. Patients underwent emergency laprotomy and correction of pathology was done.Results: Out of total 100 patients 79% were males, 21% were females, majority 45% belonged to the age group 26-35 years.  To calculate the cut off point for mortality ROC curve was constructed. ROC curve analysis predicted that Manheim’s score of 22 or more would predict mortality. Out of total 16 deaths, 14 cases had Manheim’s score of 22 or more thus, giving the score a sensitivity of 87.5% and specificity of 77.38% and overall accuracy of 79% in our study. ROC also predicted that APACHE II score of 15 or more would predict mortality. Thus, giving APACHE II score a sensitivity of 93.75%, specificity of 100% and accuracy of 99%.Conclusions: We consider MPI to be a more simpler prognostic indicator than APACHE II score.

Role of PANC-3 score to predict severe acute pancreatitis

Background: Acute pancreatitis is the most terrible of all the calamities that occur in connection with the abdominal viscera. Prediction of severity is an essential step in the management of acute pancreatitis. 50% of mortality can be reduced to 8% by its early recognition. PANC-3 score is widely available test that can be performed quickly, easy to measure with high accuracy in predicting acute pancreatitis.Methods: This cross-sectional study was conducted in the department of general surgery, VMMC and Safdarjung Hospital over 50 patients admitted with acute pancreatitis. After making the clinical diagnosis, PANC -3 score, modified ATLANTA score, APACHE II were done. CRP and CTSI (computed tomography sensitivity index) were calculated and correlated.Results: Mean age was 44.74 years and most common cause was biliary tract pathology. Mortality observed in 5 patients, 11 patients had severe disease. Sensitivity of PANC- 3 was 81.82%, specificity -92.31% with 75% PPV and 94.7% NPV.Conclusions: PANC-3 can be used to predict the severity of pancreatitis as efficiently as Modified ATLANTA classification/APACHE II. It uses only three criteria which are easily done, and available in the basic health care setup. Its interpretation does not need expertise and can be applied at the time of admission which is an advantage when compared to classical scoring systems.

Role of acute physiology and chronic health evaluation II scoring system in risk stratification and management of small bowel perforations

Background: Despite the surgical treatment, sophisticated intensive care units, latest generation antibiotics and a better understanding of pathophysiology, the morbidity and mortality rate of perforation peritonitis are still high. Patients are usually managed by subjective decision of surgeon based on which mortality is very high.Methods: This was a double-blind observational study conducted over a period of 18 months on 50 patients with small bowel perforations. Based on the acute physiology and chronic health evaluation (APACHE) II score at presentation, patients were triaged into 3 groups: group 1 (score ≤10), group 2 (score 11 to 20) and group 3 (score >20). Study population was managed by the subjective decision of the operating surgeon who was blinded off the APACHE II score of patients. Hence removing the possibility of bias and observing a correlation between surgical outcome and APACHE II score of the patient.Results: Patients with higher APACHE II score (>10) were more likely to undergo exteriorization of bowel. Length of hospital stay was also found to be increased with an increase in score. APACHE II score of 10 was found to predict mortality with significant difference between 2 groups. Below this score the mortality was 0% and above this score the mortality rate rose to 31.25%.Conclusions: APACHE II can be used as a reliable and uniform scoring system as its assessment at presentation in patients of small bowel perforations provides an insight to their surgical management as well as predicting overall outcome.

Valoración del APACHE II inicial en la unidad de cuidados intensivo emergente / Evaluation of the initial APACHE II score in the Emergency Intensive Care Unit

RESUMEN Introducción: el empleo de score pronósticos de mortalidad constituye una herramienta de gran utilidad en las unidades de cuidados intensivos, al permitir un mejor enfoque de la atención médica. Objetivo: determinar la utilidad del APACHE II en la Unidad de Cuidados Intensivos Emergentes del Hospital Celia Sánchez Manduley. Métodos: se realizó un estudio observacional, analítico, transversal en el periodo abril- junio de 2018, con 68 pacientes. Para identificar diferencias estadísticamente significativas entre las categorías de algunas de las variables estudiadas se utilizó el estadígrafo chi cuadrado, se consideró como significativo una p <0,05. Para evaluar discriminación se analizó el área bajo la curva con intervalos de confianza del 95 % además se examinó la calibración a través de la razón estandarizada de mortalidad. Resultados: las enfermedades cerebrovasculares prevalecieron en el 27,9 % de los pacientes, alcanzaron APACHE II ≥15 puntos 35 pacientes (51,4 %), la unidad de cuidados intermedio fue el servicio de destino que más pacientes admitió (39,7 %). Fallecieron 18 pacientes, de estos 14 ingresaron con un APACHE ≥15 puntos (77,7 %, p=0,009). La mortalidad observada fue de 18, la razón estandarizada de mortalidad fue de 1,04 y el Área bajo la curva fue 0,679 p=0,025 (IC: 0,538-0,820). Conclusiones: el APACHE II es una herramienta que puede ser útil para el médico de la Unidad de Cuidados Intensivos Emergentes.

ABSTRACT Introduction: the use of prognostic mortality scores is a very useful tool in intensive care units, allowing a better approach to medical care. Objective: to determine the usefulness of APACHE II in the Emergency Intensive Care Units at Celia Sanchez Manduley General Hospital. Methods: an observational, analytical and cross-sectional study was carried out in the period from April to June 2018 with 68 patients. To identify the statistically significant differences between the categories of some of the variables studied, the Chi-square statistic was used, with p <0.05 being considered significant. To calculate the discrimination, the area under the curve with 95 % confidence intervals was analyzed, and the calibration was also examined through the standardized mortality ratio. Results: cerebrovascular diseases prevailed (27,9 %), 35 patients (51,4 %) reached the APACHE II ≥15 scores, intermediate care unit was the destination service that admitted the most patients (39,7 %). Eighteen (18) patients died, of them 14 were admitted having APACHE II ≥15 scores (77,7 %, p=0.009). The mortality rate observed was 18, the standardized ratio of mortality reached 1,04, and the area under the curve was 0,679 p=0,025 (IC: 0,538-0,820). Conclusions: APACHE II can be a useful tool in intensive care units, allowing a better approach to medical care.

Apache II score in predicting surgical outcome in patients of secondary peritonitis: a prospective and observational study

Background: Peritonitis is defined as inflammation of the serosal membrane that lines the abdominal cavity and the organs contained therein. Secondary peritonitis presenting as acute generalized peritonitis is a common surgical emergency often associated with significant morbidity and mortality. Many scoring systems have been found useful in predicting the outcome in critically ill patients, thus allowing application of resources for effective use. Amongst them acute physiology and chronic health evaluation score (APACHE II), have a strong relationship to the outcome than previous groupings without consideration for systemic effect of the intra-abdominal sepsis.Methods: This study was conducted in the Department of General surgery, Sri Maharaja Hari Singh (SMHS) Hospital an associated hospital with the Government Medical College Srinagar, J&K, India. The prospective study was conducted over a period from October 2016 to September 2018 (Two Year) on 108 patients diagnosed with secondary peritonitis. Data was collected and analysed using SPSS v 20.Results: study included 108 patients with males involving 74.1% (80). The mean age of our study was 34 yr. (2-88 yr.), and 21-40 yr. (44.5%) group was mostly involved. Pain abdomen was present in 100% patients followed by nausea/vomiting (88%). Higher the APACHE VII score higher were post-operative complications (31+ score group 100%), mortality (31+ score group 100%) and less hospital stay (31+ score group 1.5 days) due to increased mortality.Conclusions: APACHE II score correlated well with postoperative complications, outcome, hospital stay. However, in patients with very high Apache score more than 30, the mean duration of hospital stay is less due to associated increased mortality during early Hospital stay.

Comparison of clinical parameters with APACHE-II, Sequential Organ Failure Assessment and Clinical Pulmonary Infection Score scores in predicting treatment outcome of patients with ventilator associated pneumonia

Background: The objective of this study was to study the multiple clinical parameters in patients with VAP and to compare the 3 scores namely, APACHE II, SOFA and CPIS in predicting the treatment outcome of patients with ventilator associated pneumonia.Methods: It was a cross sectional observational study conducted on forty patients admitted in ICU between June 2018 and July 2019, who developed VAP after admission to ICU. Logistic regression analysis was applied to estimate the predictive ability of the APACHE II, SOFA and CPIS scoring systems in assessing VAP-related mortality. A p value of <0.05 was considered significant. All analyses were performed using SPSS software version 10.Results: The sample size in our study was 40 patients. The mean age of patients was 43.4±15.9. The mean duration of mechanical ventilation before VAP onset was 8±2 days. Klebsiella species was the most common organism isolated from ET aspirate. Of the three scores only APACHE II was independent predictor of the mortality in the logistic regression analysis.Conclusions: APACHE II score is better at predicting mortality in patients with VAP as compared to SOFA and CPIS scores. Age, co-morbidities, duration of ICU stay, time of acquiring VAP, multi organ dysfunction, need for ionotropes and multi drug resistant organisms play an important role in predicting the outcome of patients.